Skip to main content
. 2015 Nov 26;16(7):497–503. doi: 10.5152/AnatolJCardiol.2015.6240

Table 5.

The characteristics of patients

Variable TASC A&B (n=259) TASC C&D (n=84) P*
Age, year 64.80±9.93 65.35±8.90 0.656
Male, n % 219 (84.6%) 84 (100%) <0.001
CAD, n % 133 (51.4%) 59 (70.2%) 0.002
Smoking, n % 120 (46.3%) 45 (53.6%) 0.249
HT, n % 129 (49.8%) 45 (53.6%) 0.549
HL, n % 80 (30.9%) 34 (40.5%) 0.105
LDL, mg/dL 136.77±33.96 154.18±53.51 0.006
HDL, mg/dL 38.35±6.62 35.89±7.12 0.004
DM, n % 87 (33.6%) 27 (32.1%) 0.807
CRF, n % 58 (22.4%) 12 (14.3%) 0.109
LVEF, % 58.25±10.14 57.69±9.88 0.658
Glucose, mg/dL 105 (31) 105 (24.5) 0.560
Creatinine, mg/dL 0.99 (0.34) 1.02 (0.26) 0.131
GFR, ml/min/1.73m2 82.49±29.40 80.73±29.57 0.634
Neutrophil 4.57±1.34 5.56±1.30 <0.001
Lymphocyte 1.64±0.52 1.44±0.56 0.003
N/L ratio 2.61 (1.30) 3.99 (2.70) <0.001
*

Chi-square test, student’s t- test and Mann-Whitney U test. CAD - coronary artery disease; CRF - chronic renal failure (Glomerular filtration rate<60 ml/min/1.73 m2); DM - diabetes mellitus; GFR - estimated glomerular filtration rate; HDL - high density lipoprotein cholesterol; HL - hyperlipdemia; HT - hypertension; LDL - low density lipoprotein cholesterol; LVEF - left ventricle ejection fraction; N/L ratio - Neutrophil/Lymphocyte ratio; PAD - peripheral artery disease; TASC - Trans Atlantic Inter-Society Consensus II classification